Sample Brief — Briefly

From: Briefly <hello@readbriefly.com> · Your Briefly for Monday, June 1

Briefly

Monday, June 1 · personalized to your interests

Here's what matters today across AI & ML, Startups, Anthropic.

Today's overview

Frontier AI regulation is accelerating — Anthropic's EU moves and a new congressional hearing signal that the policy window is narrowing faster than most founders expected. Meanwhile, YC's infrastructure-heavy S25 batch suggests the smart money is moving down the stack.

AIReuters · MIT Tech Review

Anthropic announces new model capability limits amid EU regulatory pressure

Why it matters to you: You track Anthropic — this directly affects what frontier models can do in your product's roadmap.

StartupsTechCrunch · Bloomberg

YC S25 batch: 40% of companies building AI infrastructure, not applications

Why it matters to you: Structural shift in where YC is placing bets — relevant if you're thinking about your company's layer in the stack.

AIThe Information

New benchmark shows frontier models hitting reasoning ceiling

Why it matters to you: Raises questions about the next capability leap and product roadmap timing.

PolicyPolitico · Reuters

Senate AI subcommittee schedules first mandatory hearing for foundation model labs

Why it matters to you: Compliance requirements are coming — earlier awareness means more runway to prepare.

StartupsCrunchbase

AI infrastructure funding hits $8B in Q1 — outpacing application layer 3:1

Why it matters to you: Capital is concentrating at the infrastructure layer — signals where the defensible businesses are being built.

From: Briefly <hello@readbriefly.com> · Your Briefly for Monday, June 1

Briefly

Monday, June 1 · personalized to your interests

Here's what matters today across Venture capital, Finance & macro, Startups.

Today's overview

The macro picture tightened this morning — hotter-than-expected inflation data is pushing rate cut expectations to Q4 at the earliest, which compresses multiples across the board. Sequoia's new fund timing looks deliberate given the dislocation.

FinanceWSJ · FT

Fed signals one rate cut in 2025 as inflation data comes in hotter than expected

Why it matters to you: Tighter-for-longer rates compress startup valuations and slow LP commitments — key signal for your deployment pace.

VCTechCrunch · Bloomberg

Sequoia raises $2.5B new fund as AI deal flow accelerates

Why it matters to you: Signals where the market is heading and who you'll be competing with for deals.

StartupsThe Information

Series A valuations drop 18% YoY as investors push for profitability

Why it matters to you: Directly affects entry pricing for your next deal — market is repricing early-stage risk.

FinanceReuters

Treasury yields climb to 4.8% on stronger-than-expected jobs report

Why it matters to you: Rising yields historically correlate with reduced VC deployment — watch LP sentiment in coming weeks.

VCCrunchbase

Q1 2025 global VC funding down 12% — but AI deals up 40%

Why it matters to you: The bifurcation is sharpening — non-AI deals are getting harder while AI remains competitive.

From: Briefly <hello@readbriefly.com> · Your Briefly for Monday, June 1

Briefly

Monday, June 1 · personalized to your interests

Here's what matters today across Biotech & health, Research & academia, Policy & regulation.

Today's overview

A landmark FDA approval and a new AlphaFold capability release are reshaping the drug discovery landscape simultaneously — the regulatory and computational barriers are falling faster than most timelines assumed. NIH's AI guidance adds a new compliance layer worth watching.

BiotechSTAT News · Nature

FDA approves first CRISPR-based treatment for sickle cell disease

Why it matters to you: Landmark approval that opens the regulatory door for gene-editing therapies across the field.

ResearchScience · MIT News

AlphaFold 3 predicts protein-drug interactions with near-lab accuracy

Why it matters to you: Could accelerate your drug discovery pipeline significantly — reduces wet lab validation burden.

PolicyReuters · Fierce Pharma

NIH proposes new rules on AI use in clinical trial design

Why it matters to you: Regulatory signal that will affect how you can use AI tools in your research methodology.

BiotechSTAT News

Pfizer acquires AI-driven drug discovery startup for $1.4B

Why it matters to you: Signals big pharma's valuation of AI-native drug discovery — sets M&A precedent for the sector.

ResearchNature

New RNA-targeting approach shows promise in neurodegeneration models

Why it matters to you: You track research — early signal in a space with few effective therapeutic options.

From: Briefly <hello@readbriefly.com> · Your Briefly for Monday, June 1

Briefly

Monday, June 1 · personalized to your interests

Here's what matters today across Climate & energy, Policy & regulation, Finance & macro.

Today's overview

Solar deployment is outpacing every forecast while the EPA tightens methane rules — the policy and market signals are both pointing in the same direction for clean energy. The green bond market hitting $500B is the capital confirmation.

ClimateBloomberg · FT

IEA: solar capacity additions hit record 400GW in 2024, outpacing all forecasts

Why it matters to you: The scale shift changes the economics of every clean energy project you're evaluating.

PolicyE&E News · Reuters

EPA finalizes stricter methane rules for oil and gas operations

Why it matters to you: New compliance requirements that directly affect the sectors you track and work with.

FinanceWSJ · Bloomberg

Green bond issuance hits $500B as institutional investors demand ESG exposure

Why it matters to you: Signals growing capital availability for climate projects — relevant to your funding landscape.

ClimateInside Climate News

New study: grid-scale battery storage costs drop 40% in 18 months

Why it matters to you: Storage economics are the remaining bottleneck for renewable baseload — this accelerates the timeline.

PolicyReuters

EU carbon border tax takes effect, affecting $10B in annual imports

Why it matters to you: First major carbon pricing mechanism affecting global trade flows — watch for US response.

See exactly what
you'd receive.

Your brief starts tomorrow.

See exactly whatyou'd receive.

Your brief starts tomorrow.

See exactly what
you'd receive.